Fetal and Infant Growth Patterns and Risk of Lower Lung Function and Asthma. The Generation R Study

Herman T den Dekker1,2,3, Vincent W V Jaddoe1,3,4, Irwin K Reiss5

  • 11 Generation R Study Group.

Insights

Fetal and infant growth patterns significantly impact childhood lung function, with restricted or accelerated growth linked to reduced lung capacity. However, neither pattern was associated with childhood asthma development.

Area of Science:

  • Pediatric respiratory health
  • Growth and development studies
  • Epidemiology

Background:

  • Lower birth weight in children is a known risk factor for developing asthma symptoms.
  • Understanding the impact of fetal and infant growth on long-term respiratory health is crucial for early intervention.

Purpose of the Study:

  • To investigate the association between fetal and infant growth trajectories and lung function at age 10.
  • To determine if fetal and infant growth patterns are linked to the incidence of childhood asthma.

Main Methods:

  • A prospective cohort study of 5,635 children, with growth assessed via ultrasounds and measurements at birth and up to 12 months.
  • Lung function (FEV1, FVC, FEF75%) measured at age 10 using spirometry; asthma assessed via parental questionnaire.
  • Statistical analyses included multiple and conditional regression to evaluate growth percentile changes (restricted/accelerated) and their impact on lung function and asthma.

Main Results:

  • Greater fetal and early infant weight was associated with higher FEV1 and FVC, but later infant weight gain (3 months) correlated with lower FEV1/FVC and FEF75%.
  • Restricted fetal growth was linked to reduced childhood lung function, with effects modified by infant growth patterns.
  • Accelerated fetal growth, particularly when followed by accelerated infant growth, was associated with higher FVC but lower FEV1/FVC.

Conclusions:

  • Both restricted and accelerated fetal and infant weight growth patterns can negatively affect lung function development in children.
  • These growth deviations may predispose children to respiratory diseases later in life, highlighting the importance of monitoring fetal and infant growth.
  • No significant association was found between fetal and infant weight growth patterns and the development of childhood asthma.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.9K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K